| Dr Ryan Michael Johnson, DO | |
|
1300 Franklin Ave Ste 110, Normal, IL 61761-3799 | |
| (309) 268-3502 | |
| Not Available |
| Full Name | Dr Ryan Michael Johnson |
|---|---|
| Gender | Male |
| Speciality | Neurological Surgery |
| Location | 1300 Franklin Ave Ste 110, Normal, Illinois |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1932559119 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207T00000X | Neurological Surgery | 125069500 (Illinois) | Primary |
| Entity Name | Carle Health Care Incorporated |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1154653947 PECOS PAC ID: 3577515774 Enrollment ID: O20100513000829 |
News Archive
The Brain & Behavior Research Foundation today announced its 2015 Independent Investigator Grants which will award $3.9 million in funding to 40 mid-career scientists from 30 institutions in 16 countries.
Scientists today published catalogs of the fruit fly and roundworm's functional genomic elements: DNA sequences in the genome that carry the instructions and determine which genes are turned on and off at various times in different cells.
The Wellcome Trust and Merck & Co., Inc. today announced the creation of the MSD Wellcome Trust Hilleman Laboratories (www.hillemanlaboratories.in), the first of its kind research and development joint venture with a not-for-profit mission to focus on developing affordable vaccines to prevent diseases that commonly affect low-income countries.
Researchers at Kanazawa University report in Nature Communications the mechanism making some lung-cancer patients resistant to the drug osimertinib.
The combination of the clot-busting drug tPA with an infusion of the antiplatelet drug eptifibatide dissolves blood clots safely and more quickly than tPA alone, a study led by University of Cincinnati (UC) researchers has found.
› Verified 9 days ago
| Entity Name | Carle West Physician Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1467074138 PECOS PAC ID: 8921420308 Enrollment ID: O20200613000147 |
News Archive
The Brain & Behavior Research Foundation today announced its 2015 Independent Investigator Grants which will award $3.9 million in funding to 40 mid-career scientists from 30 institutions in 16 countries.
Scientists today published catalogs of the fruit fly and roundworm's functional genomic elements: DNA sequences in the genome that carry the instructions and determine which genes are turned on and off at various times in different cells.
The Wellcome Trust and Merck & Co., Inc. today announced the creation of the MSD Wellcome Trust Hilleman Laboratories (www.hillemanlaboratories.in), the first of its kind research and development joint venture with a not-for-profit mission to focus on developing affordable vaccines to prevent diseases that commonly affect low-income countries.
Researchers at Kanazawa University report in Nature Communications the mechanism making some lung-cancer patients resistant to the drug osimertinib.
The combination of the clot-busting drug tPA with an infusion of the antiplatelet drug eptifibatide dissolves blood clots safely and more quickly than tPA alone, a study led by University of Cincinnati (UC) researchers has found.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Ryan Michael Johnson, DO 2000 N Linden St Apt C305, Normal, IL 61761-5337 Ph: (740) 632-3117 | Dr Ryan Michael Johnson, DO 1300 Franklin Ave Ste 110, Normal, IL 61761-3799 Ph: (309) 268-3502 |
News Archive
The Brain & Behavior Research Foundation today announced its 2015 Independent Investigator Grants which will award $3.9 million in funding to 40 mid-career scientists from 30 institutions in 16 countries.
Scientists today published catalogs of the fruit fly and roundworm's functional genomic elements: DNA sequences in the genome that carry the instructions and determine which genes are turned on and off at various times in different cells.
The Wellcome Trust and Merck & Co., Inc. today announced the creation of the MSD Wellcome Trust Hilleman Laboratories (www.hillemanlaboratories.in), the first of its kind research and development joint venture with a not-for-profit mission to focus on developing affordable vaccines to prevent diseases that commonly affect low-income countries.
Researchers at Kanazawa University report in Nature Communications the mechanism making some lung-cancer patients resistant to the drug osimertinib.
The combination of the clot-busting drug tPA with an infusion of the antiplatelet drug eptifibatide dissolves blood clots safely and more quickly than tPA alone, a study led by University of Cincinnati (UC) researchers has found.
› Verified 9 days ago
Paul Jene Gustin, DO Neurological Surgery Medicare: Medicare Enrolled Practice Location: 1300 Franklin Ave, Normal, IL 61761 Phone: 309-268-3502 | |
Dr. Gina Nicole Guglielmi, DO Neurological Surgery Medicare: Medicare Enrolled Practice Location: 1304 Franklin Ave, Normal, IL 61761 Phone: 309-454-1400 | |
Dr. Joshua Sterling Bentley, D.O. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 1304 Franklin Ave, Normal, IL 61761 Phone: 309-268-3713 |